2025-12-24 - Analysis Report
Okay, here's a comprehensive analysis of Northrop Grumman Corp (NOC) based on the data provided.

**1) Return Rate Comparison and Alpha/Beta Analysis**

*   **Company Overview:** Northrop Grumman Corp is a global aerospace and defense technology company.
*   **Return Rate Comparison:**
    *   NOC Cumulative Return: 47.50%
    *   VOO (S&P 500) Cumulative Return: 100.88%
    *   Divergence: -53.38% (NOC underperformed the S&P 500 significantly)
    *   Relative Divergence: 5.2 (Indicates the divergence is close to its historical low).

*   **Alpha/Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 46.0% | 65.6% | 17.0% | 0.0 | 44.8 |
| 2016-2018  | -2.0% | 74.3% | -17.0% | 0.0 | 35.8 |
| 2017-2019  | 17.0% | 79.2% | -5.0% | 0.9 | 50.3 |
| 2018-2020  | -28.0% | 79.9% | -52.0% | 0.8 | 44.5 |
| 2019-2021  | 43.0% | 79.9% | -4.0% | 0.8 | 56.5 |
| 2020-2022  | 18.0% | 79.9% | 19.0% | 0.3 | 79.7 |
| 2021-2023  | 24.0% | 82.7% | 23.0% | 0.2 | 68.4 |
| 2022-2024  | -15.0% | 82.7% | -36.0% | 0.2 | 68.6 |
| 2023-2025  | -3.0% | 82.1% | -68.0% | 0.1 | 83.0 |

*   **Analysis:** NOC has significantly underperformed the S&P 500 over the provided period. The Alpha figures are mixed but largely negative, indicating that NOC is generating less return than expected for its level of risk (as measured by Beta). The Beta values are consistently low, indicating the stock has low correlation with the market. The MDD (Maximum Drawdown) is very high which indicates high volatility.

**2) Recent Stock Price Fluctuations**

*   Current Close: $568.46
*   Last Market Data: Price: $580.06, Previous Close: $584.66, Change: -$0.79
*   5-day SMA: $567.34
*   20-day SMA: $560.77
*   60-day SMA: $581.32

*   **Analysis:** The stock price is slightly below the 5-day SMA, and 20-day SMA. However, it is significantly below the 60-day SMA. This suggest recent negative price momentum. The slight negative change from the last market data suggests continued downward pressure.

**3) Technical Indicators and Expected Return**

*   MRI: 0.8 (Medium Investment Recommended)
*   RSI: 65.35 (approaching overbought)
*   PPO: 0.39
*   Hybrid Signal: `cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Dividend_2.31 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)` (A buy signal is generated.)
*   Recent (20 days) relative divergence change: -0.5 (Indicates a short-term decline)
*   Expected Return: -151.2% (Significant underperformance compared to S&P 500 if held long-term)

*   **Analysis:** The Market Risk Indicator (MRI) suggests a medium investment recommendation, while the RSI indicates the stock is approaching overbought conditions. The Hybrid signal is giving a buy signal. The negative expected return suggests a high risk of underperformance relative to the S&P 500 over the long term. The recent relative divergence change of -0.5 indicates a recent short-term decline.

**4) Recent News & Significant Events**

*   **Mixed Sentiment:** The news headlines present a mixed picture.
    *   **Negative:** "3 Reasons to Sell NOC" and "Northrop Grumman Corporation $NOC Shares Sold by Voya Investment Management LLC" indicate bearish sentiment.
    *   **Positive:** "Analysts See a 19% Upside to Northrop Grumman Corporation (NOC)" and "Northrop Grumman (NOC): Has the Recent Drift Lower Opened a Valuation Opportunity?" suggest potential for price appreciation.
    *   **Neutral:** "Northrop Grumman Announces Fourth Quarter and Full-Year 2025 Earnings Release Date and Webcast Details" and "Northrop Grumman (NOC) Stock: Latest News, Price Targets and Investment Outlook as of December 7, 2025" are informational.
*   **Overall:** The news sentiment is mixed, with both positive and negative catalysts potentially impacting the stock.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean = 2.04)
*   **Target Price:** Average: $662.68, High: $770.00, Low: $533.00
*   **Recent Rating Changes:** No rating changes were provided.

*   **Analysis:** The analyst consensus is positive (Buy rating), and the average target price suggests a potential upside from the current price.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-21 | 7.69 | 10.42 B$  |
| 2025-07-22 | 8.17 | 10.35 B$  |
| 2025-04-22 | 3.33 | 9.47 B$   |
| 2024-10-24 | 7.02 | 10.00 B$  |
| 2025-10-21 | 7.02 | 10.00 B$  |

*   **Analysis:** Revenue has fluctuated. EPS has been relatively consistent. The EPS figure in 2025-04-22 was unusually low, while revenues were steady. This would warrant further investigation. The most recent EPS is above last year's EPS for the same quarter, indicating growth.

**6) Financial Information (Revenue, Profitability, Capital)**

*   **Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $10.42B    | 21.37%        |
| 2025-06-30   | $10.35B    | 21.35%        |
| 2025-03-31   | $9.47B     | 16.69%        |
| 2024-12-31   | $10.69B    | 18.08%        |
| 2024-09-30   | $10.00B    | 21.07%        |

*   **Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-09-30   | $15.99B    | 6.88% |
| 2025-06-30   | $15.47B    | 7.59% |
| 2025-03-31   | $14.98B    | 3.21% |
| 2024-12-31   | $15.29B    | 8.27% |
| 2024-09-30   | $14.75B    | 6.96% |

*   **Analysis:** Revenue has been relatively stable, with the most recent quarter showing a strong revenue. The profit margin has been consistent, with the lowest margin in 2025-03-31. Equity has generally been increasing. ROE (Return on Equity) has fluctuated. The ROE was particularly low in 2025-03-31.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** NOC has significantly underperformed the S&P 500 historically and is projected to continue to underperform.
*   **Mixed Signals:** Technical indicators and news sentiment are providing mixed signals, with some indicators suggesting a potential buy while others point to caution.
*   **Analyst Optimism:** Analysts have a generally positive outlook on the stock.
*   **Stable Financials:** Revenue and profitability are relatively stable.
*   **Low Beta:** Low Beta suggests the stock is not correlated with the market.

**Conclusion:**

Based on the data, NOC appears to be a risky investment. While analysts have a positive outlook, the stock's historical underperformance compared to the S&P 500, the negative expected return, and the mixed technical signals warrant caution. A potential investor needs to weigh the analyst consensus against the historical data and consider their own risk tolerance. Further investigation into the reasons for the 2025-04-22 EPS dip is warranted.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.